secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0001641172-25-003913
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo shareholders approve authorized share increase to 75M and board declassification
--------------------------------------------------------------------------------

- Stockholders approved raising authorized common shares from 50M to 75M at the April 4, 2025 Annual Meeting.
- Certificates of amendment filed with Delaware on April 11, 2025.
- Stockholders also approved declassification of the Board; all directors will stand for annual election starting next meeting.
- Board adopted conforming Bylaws amendment effective upon the declassification charter amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000164117225003913/0001641172-25-003913-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000164117225003913/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003913

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer